Whistleblower Rewards
This archive displays posts tagged as including whistleblower rewards. You may also be interested in the following pages:
August 25, 2021
A California-based provider of home respiratory services and durable medical equipment has agreed to pay $3.3 million to the United States and States of California and Nevada to settle allegations of defrauding Medicare and Medicaid. The claims against SuperCare Health, Inc. were brought in a 2018 qui tam suit by respiratory therapist Benjamin Martinez, who alleged that the provider billed for non-invasive ventilators (NIVs) that were no longer needed or being used by patients. CA AG; USAO CDCACatch of the Week: Telemedicine Company Owner Charged in $784 Million Kickback Scheme
Posted 08/20/21
August 19, 2021
Nevada Advanced Pain Specialists agreed to pay $1 million to resolve allegations that it submitted false claims for confirmatory urine drug testing performed without regard to the results of presumptive tests that had been performed. The allegations were first brought in a qui tam lawsuit filed by an whistleblower Omni Healthcare, Inc., which will receive a relator’s share of $150,000 of the settlement. USAO MASEC Chairman Views Cryptocurrency Markets as the “Wild West” and Calls for More Investor Protection
Posted 08/13/21
August 10, 2021
The SEC has made awards of nearly $6 million total to two whistleblowers. According to the agency, one whistleblower received $3.5 million for providing valuable new information that expanded the geographic scope of an existing investigation. The second whistleblower received more than $2.4 million for providing information about previously unknown conduct. SECAugust 6, 2021
The SEC has awarded more than $3.5 million to three whistleblowers whose information and assistance led to two separate enforcement actions. In the first order, an individual received approximately $2 million for providing information that launched an investigation into an ongoing fraud. In the second order, one whistleblower received approximately $1 million and a second whistleblower received approximately $500,000 for providing information that assisted the agency in an existing investigation. SECAugust 5, 2021
Ascension Michigan and related hospitals, which allegedly billed federal healthcare programs for services performed by a gynecologic oncologist that were not medically necessary or rendered as represented, has agreed to pay $2.8 million to resolve their liability under the False Claims Act. The settlement resolves claims from a 2017 qui tam suit by whistleblowers Pamela Satchwell, Dawn Kasdorf, and Bethany Silva-Gomez, that Ascension knowingly submitted claims for medically unnecessary hysterectomies and chemotherapy, and unrendered evaluation and management services. Spurred by patient complaints, Ascension launched an internal investigation, ultimately self-disclosing the misconduct to the government in 2018. As part of the settlement, Satchwell, Kasdorf, and Silva-Gomez will share in a $532,000 award. USAO EDMICatch of the Week: Waived Copayments and “Free” Glucometers Result in $160 Million Recovery in Whistleblower Action Against Previously-Barred Arriva Medical
Posted 08/4/21
